EGFR and lung carcinoma: Surprisingly, we also found that suppressing EGFR edndocytosis with inhibitors (dyansore and dynole 34-2) resulted in reduced cell viability and increased apoptotic cell death in gefitinib-insensitive lung cancer cells with wtEGFR, and that inhibitory effect was more enhanced in combination with gefitinib.